Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

China Implements 30-Day Review for “Simple” M&A Transactions

publication date: Feb 26, 2014
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China has introduced new M&A review procedures that will shorten approval times for most transactions to 30 days. The Ministry of Commerce estimates that up to 60% of all M&A events will qualify for this new fast-track decision. The major determinant for fast-track approval is market share: the proposed tie-up cannot creat a company with a commanding position in its market. If the resulting market share is large, MOFCOM will require as long as 180 days to render an opinion. More details....

This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at this event:
 
 
Hope to see you there!
 
ChinaBio® Events
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors